Multimedia content is supported by an unrestricted educational grant from:

Course Description

Target Audience
This educational program is intended for physicians and other healthcare professionals with special education and training in microbiology or infectious diseases who are interested in the identification, diagnosis, and management of invasive fungal infections.

Educational Objectives
After successfully completing this continuing medical education program participants should be able to:

• Comment on the impact of echinocandin-containing therapy regimens for immunocompromised patient
• Comment on the clinical value of infection profiles
• Discuss challenges in treating emergent disease in stable patients

Continuing Medical Education for Physicians
Imedex^®, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Imedex^®, Inc. designates this educational activity for a maximum of 1.5 category 1 credits toward the AMA Physician’s Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity.

Credits will be awarded upon completion and submission of the self-assessment questions, evaluation form, and CME credit request form to:

Imedex^®, Inc.
4325 Alexander Drive
Alpharetta, GA 30022
Fax: +1(770) 751 7334
Deadline for CME Credit submission: May 15, 2007

Unapproved and Investigational Uses of Drugs and Devices
This webcast and CD-ROM may contain information about experimental and other uses of drugs or devices that are not currently approved by the Food and Drug Administration (FDA) and/or other national regulatory agencies in the United States and other countries. Participants in the United States are encouraged to consult the FDA-approved product labeling for any drug or device mentioned in this program before use. Participants from other countries should consult with their respective regulatory authorities.

The opinions expressed in this webcast and CD-ROM are the opinions of the authors and do not necessarily reflect the opinions of Imedex^®, Inc. or Merck.

Program Organizer
Imedex^®, Inc.
4325 Alexander Drive
Alpharetta, GA 30022
Tel.: +1 (770) 751 7332
Fax: +1(770) 751 7334

Disclosure of Financial Interests
As an accredited provider of Continuing Medical Education, Imedex, Inc. is required to ask speakers to disclose any real or apparent conflict of interest they may have as related to the contents of their presentation(s). The existence of commercial or financial interests of speakers related to the subject matter of their presentation(s) should not be construed as implying bias or decreasing the value of their presentation(s). However, disclosure should help participants form their own judgments.

All speakers were independently selected by the organizing committee. Those speakers who disclosed affiliations or financial interests with the commercial organizations involved with products, to which they may refer, are listed below.

1=grant/research support
2=consultant
3=speaker’s bureau
4=stock shareholder
5=other support

The following speakers have reported an affiliation with non-supporting companies of this webcast & CD-ROM:

• John Graybill, MD - F2G², Vicuron^1,2
• George Karam, MD - Pfizer³
• Thomas F. Patterson, MD, FACP - Affinium Pharmaceuticals², Basilea², Diversa², Eisai Co. Ltd.², J. Uriach & Cia.S.A.², MedicNova, Inc.², Microbia Inc.², Nektar Therapeutics², Rib-Xpharmaceuticals², Human Genome Sciences Inc./Cogenesys²

The following speakers have reported an affiliation with the supporter of this webcast & CD-ROM:

John Graybill, MD^1,2,3
George Karam, MD³
Thomas F. Patterson, MD, FACP^1,2,3

Imedex^®, Inc. is an independent provider of Continuing Medical Education. Imedex, Inc. has no proprietary or financial interest in medical or healthcare products over which the FDA has regulatory authority.

©2006 Imedex^®, Inc. All rights reserved. Reproduction in whole or part is prohibited without prior written consent from Imedex and contributing faculty.

Systems Requirements

• Pentium 500 processor or greater
• Windows 98/NT/2000/XP or Mac OS 9/X
• Microsoft Internet Explorer 5.5 or later
• Windows Media Player 9.0 or later
• 128 MB of RAM
• 10X CD-ROM drive
• Monitor settings: High color at 800 x 600 pixels
• Sound card and speakers
• Abstracts require Adobe Acrobat Reader Directions
• Insert CD into CD-ROM drive
• CD will automatically start if autoplay is enabled. If autoplay is disabled select My Computer then your
  CD-ROM drive and double click the START icon.

Audio troubleshooting
This Focus on Fungal Infections 16 CD-ROM is designed to work on most Windows systems. There is a known incompatibility with Windows XP users running Windows Media Player version 8. These users will be able to view video, but will not hear the accompanying audio. With an open internet connection while a presentation is playing, the necessary file will automatically download. Click yes when the security warning prompts you to install the file. This incompatibility can also be resolved by updating to Windows Media Player 9 at: www.microsoft.com. Click on “downloads” and type Media Player 9 into the search field.